Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $7.54 - 0.08 (1.05%)
ExchangeNASDAQ GS
Volume98,606
Today's Open$7.55
Previous Close$7.62
Data as of 02/24/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $7.54 with a 52 week high of $21.00 and a 52 week low of $7.43.
Recent News

February 20, 2017

NantHealth to Showcase New Oncology Solution Suite, Advanced Medication Adherance Solution and the Latest in Device Connectivity at HIMSS 2017 Annual Conference

Products transform the way critical diseases like cancer are known and treated NantHealth to exhibit in booth #5561 and provide live demos on the Interoperability Showcase™ Floor ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 20, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that it will be exhibiting its new suite of oncology solutions at booth #5561 and provi...

Read More >

December 19, 2016

NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9

CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 19, 2016-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017, at 5 p.m. Pacific Standard Time at the Westin St. Francis Hotel in San Francisco. An audio-only webcast of the presentation will be available at www.NantHealth.com. ...

Read More >

December 16, 2016

NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes

CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 16, 2016-- NantHealth, Inc. (Nasdaq: NH) today announced the pricing of an aggregate of $100 million principal amount of 5.50% Convertible Senior Notes due 2021 (the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Act"), and a separate concurrent private placement under Section 4(a)(2) of the Act to...

Read More >

Upcoming Events
There are currently no events scheduled.